These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8572847)

  • 21. Current treatment options for osteoporosis.
    Adachi JD
    J Rheumatol Suppl; 1996 Aug; 45():11-4. PubMed ID: 8856645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid hormone use and fractures.
    Bauer DC
    Arch Intern Med; 1996 Feb; 156(3):341-2, 344. PubMed ID: 8572848
    [No Abstract]   [Full Text] [Related]  

  • 23. [The interest of biochemical markers of bone turnover for monitoring treatment of postmenopausal osteoporosis].
    Kalaï E; Bahlous A; Makdouli A; Sahli H; Klouz A; Lakhal M; Sellami S; Abdelmoula J
    Tunis Med; 2008 Feb; 86(2):122-7. PubMed ID: 18444527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
    McClung MR; Siris E; Cummings S; Bolognese M; Ettinger M; Moffett A; Emkey R; Day W; Somayaji V; Lee A
    Menopause; 2006; 13(3):377-86. PubMed ID: 16735934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postmenopausal osteoporosis: when is it necessary to perform laboratory testing? Which testing strategy?].
    Frayssinet C; Trémollieres F
    Gynecol Obstet Fertil; 2008 Jun; 36(6):656-8. PubMed ID: 18539507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatments for osteoporosis in postmenopausal women.
    Brockie J
    Community Nurse; 1999 Jul; 5(6):32-3. PubMed ID: 10524029
    [No Abstract]   [Full Text] [Related]  

  • 29. Decline of thyroid hormones following preoperative therapeutic plasma exchange for stabilization of thyrotoxicosis.
    Leow MK
    J Clin Apher; 2010; 25(6):362-3. PubMed ID: 20806413
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone density in apheresis donors compared with blood donors.
    Boot C; Luken J
    Transfus Apher Sci; 2013 Apr; 48(2):147. PubMed ID: 23809808
    [No Abstract]   [Full Text] [Related]  

  • 31. A cautionary tale: inappropriate drug treatment after false-positive diagnosis of thyrotoxicosis.
    Stubbs PJ; Oppert SA; Collinson PO
    Clin Chem; 1990 Jul; 36(7):1381-3. PubMed ID: 2372960
    [No Abstract]   [Full Text] [Related]  

  • 32. Vitamins and bone health in women.
    Pines A
    Climacteric; 2013 Oct; 16(5):601-2. PubMed ID: 24032441
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypogonadal bone loss: sex steroids or gonadotropins?
    Williams GR
    Endocrinology; 2007 Jun; 148(6):2610-2. PubMed ID: 17507579
    [No Abstract]   [Full Text] [Related]  

  • 34. Unintentional thyrotoxicosis factitia due to a diet pill.
    Braunstein GD; Koblin R; Sugawara M; Pekary AE; Hershman JM
    West J Med; 1986 Sep; 145(3):388-91. PubMed ID: 3765621
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis of postmenopausal osteoporosis.
    Raisz LG
    Rev Endocr Metab Disord; 2001 Jan; 2(1):5-12. PubMed ID: 11704980
    [No Abstract]   [Full Text] [Related]  

  • 36. Practical strategy for diagnosing occult thyrotoxicosis in patients with paroxysmal supraventricular arrhythmias.
    Benvenga S; Calzi LL; Vermiglio F; Trimarchi F
    J R Soc Med; 1988 Mar; 81(3):186. PubMed ID: 3357169
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid hormones and osteoporosis.
    Liel Y
    Arch Intern Med; 1996 Feb; 156(3):341. PubMed ID: 8572847
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis].
    Zatońska K; Bolanowski M
    Pol Merkur Lekarski; 2000 May; 8(47):356-9. PubMed ID: 10944962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormonal and biochemical parameters in postmenopausal osteoporosis].
    Dourador EB; de Falco V; Chahade WH; Cossermelli W; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(2):60-2. PubMed ID: 9435397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.